000 01629 a2200469 4500
005 20250517055356.0
264 0 _c20160829
008 201608s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.5657
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSpel, Lotte
245 0 0 _aNatural killer cells facilitate PRAME-specific T-cell reactivity against neuroblastoma.
_h[electronic resource]
260 _bOncotarget
_cNov 2015
300 _a35770-81 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntigens, Neoplasm
_xmetabolism
650 0 4 _aCancer Vaccines
650 0 4 _aCells, Cultured
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHLA-A2 Antigen
_xmetabolism
650 0 4 _aHumans
650 0 4 _aImmunity, Innate
650 0 4 _aImmunodominant Epitopes
_xmetabolism
650 0 4 _aImmunotherapy, Adoptive
650 0 4 _aInterferon-gamma
_xmetabolism
650 0 4 _aKiller Cells, Natural
_ximmunology
650 0 4 _aNeuroblastoma
_ximmunology
650 0 4 _aPeptide Fragments
_xmetabolism
650 0 4 _aT-Lymphocytes, Cytotoxic
_ximmunology
650 0 4 _aTumor Escape
700 1 _aBoelens, Jaap-Jan
700 1 _avan der Steen, Dirk M
700 1 _aBlokland, Nina J G
700 1 _avan Noesel, Max M
700 1 _aMolenaar, Jan J
700 1 _aHeemskerk, Mirjam H M
700 1 _aBoes, Marianne
700 1 _aNierkens, Stefan
773 0 _tOncotarget
_gvol. 6
_gno. 34
_gp. 35770-81
856 4 0 _uhttps://doi.org/10.18632/oncotarget.5657
_zAvailable from publisher's website
999 _c25339572
_d25339572